LEFKOFF KYLE sold 63.6% of their position (35K shares) of ARRAY BIOPHARMA INC on the open market
Open‑market sale worth $721.1K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 2/8/2019ACC: 0001562180-19-000863
-35K
Net shares
Net seller
$721.1K
Total sold
3
Open market trades
0B · 3S
5
Total transactions
25K acquired · 60K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+25K
Price / share
$10.47
Trade value
$261.75K
% of position
110.0%
2/6/2019
22.72K→47.72K
Common Stock
Direct
Shares
−25K
Price / share
$20.51
Trade value
$512.69K
% of position
52.4%
2/6/2019
47.72K→22.72K
Common Stock
Indirect
Shares
−5K
Price / share
$20.82
Trade value
$104.12K
% of position
16.7%
2/6/2019
30K→25K
Common Stock
Indirect
Shares
−5K
Price / share
$20.85
Trade value
$104.26K
% of position
20.0%
2/6/2019
25K→20K
Total
Net shares
−10K
Net value
-$459.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/6/2019 | M · Option Exercise | +25K | $10.47 | $261.75K | 110.0% | 22.72K | 47.72K |
| Common Stock Direct | 2/6/2019 | S · Sale | −25K | $20.51 | $512.69K | 52.4% | 47.72K | 22.72K |
| Common Stock Indirect | 2/6/2019 | S · Sale | −5K | $20.82 | $104.12K | 16.7% | 30K | 25K |
| Common Stock Indirect | 2/6/2019 | S · Sale | −5K | $20.85 | $104.26K | 20.0% | 25K | 20K |
| Total | −10K | -$459.32K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
25K shares
Shares
−25K
Strike price
10.47
Held after
0.00
Exercisable
—
2/6/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock25K shares | 2/6/2019 | M · Option Exercise | −25K | 10.47 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned15K
Total
15K indirect15K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 15K | Indirect |
| Total | 15K | 15K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported